Deadline: 07-Oct-2025
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) has announced a new Notice of Funding Opportunity (NOFO) to support innovative research on the use of digital health technologies (DHT) for the management of diabetes.
This initiative aims to evaluate the efficacy of emerging digital tools and approaches to improve disease management, prevention, diagnosis, and treatment, with a focus on diabetes and related conditions.
The program encourages clinical trials and research designed to generate strong efficacy data that can inform larger, multicenter effectiveness studies in the future. Of particular interest are multimodal interventions—such as combining continuous glucose monitoring (CGM) with telemedicine or patient support—that can provide continuous, real-world insights into diabetes management. Meaningful engagement of patients, caregivers, clinicians, and community stakeholders will be a key requirement to ensure the research aligns with the real-world needs of people with diabetes (PWD).
Research areas of focus include a broad range of digital health applications, such as CGM for type 2 diabetes and prediabetes, digital activity monitoring, mobile applications for nutrition tracking, telemedicine and peer-support platforms, gaming and gamification strategies for diabetes education, and interventions that promote the adoption, sustainability, and accessibility of DHT across diverse patient populations. Studies evaluating cost-effectiveness, digital literacy, patient empowerment, and quality of life outcomes are also welcomed.
The program anticipates awarding three grants between FY 2026 and FY 2027, with direct costs of $1.5 million allocated in FY 2026, $3.0 million spread across FY 2027–2030, and $1.5 million in FY 2031. Projects may last up to five years, with funding levels expected to align with the scope of proposed research.
Eligible applicants include a wide range of institutions and organizations, such as public and private higher education institutions, nonprofit organizations, for-profit companies, state and local governments, federally recognized tribal governments, and faith-based or community organizations. However, non-U.S. entities are not eligible to apply.
By investing in innovative digital health approaches, this funding opportunity seeks to transform the way diabetes is managed and to provide new pathways for improving outcomes for millions of people affected by type 1 and type 2 diabetes.
For more information, visit Grants.gov.